-
1
-
-
33645294070
-
Oncomirs-microRNAs with a role in cancer
-
Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 259-269
-
-
Esquela-Kerscher, A.1
Slack, F.J.2
-
2
-
-
73349125465
-
MicroRNAs in cancer: Small molecules with a huge impact
-
Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848-56.
-
(2009)
J Clin Oncol
, vol.27
, pp. 5848-5856
-
-
Iorio, M.V.1
Croce, C.M.2
-
3
-
-
33644768174
-
Control of translation and mRNA degradation by miRNAs and siRNAs
-
Valencia-Sanchez MA, Liu J, Hannon GJ et al. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006; 20: 515-24.
-
(2006)
Genes Dev
, vol.20
, pp. 515-524
-
-
Valencia-Sanchez, M.A.1
Liu, J.2
Hannon, G.J.3
-
4
-
-
84858126071
-
MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review
-
Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012; 4: 143-59.
-
(2012)
EMBO Mol Med
, vol.4
, pp. 143-159
-
-
Iorio, M.V.1
Croce, C.M.2
-
5
-
-
84902464275
-
MicroRNAs and the cancer phenotype: Profi ling, signatures and clinical implications
-
Stahlhut C, Slack FJ. MicroRNAs and the cancer phenotype: profi ling, signatures and clinical implications. Genome Med 2013; 5: 111.
-
(2013)
Genome Med
, vol.5
, pp. 111
-
-
Stahlhut, C.1
Slack, F.J.2
-
6
-
-
70349320158
-
Causes and consequences of microRNA dysregulation in cancer
-
Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704-14.
-
(2009)
Nat Rev Genet
, vol.10
, pp. 704-714
-
-
Croce, C.M.1
-
7
-
-
84876578733
-
Targetome profi ling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis
-
Hoffman AE, Liu R, Fu A et al. Targetome profi ling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis. Cancer Epidemiol Biomarkers Prev 2013; 22: 327-36.
-
(2013)
Cancer Epidemiol Biomarkers Prev
, vol.22
, pp. 327-336
-
-
Hoffman, A.E.1
Liu, R.2
Fu, A.3
-
8
-
-
84883094004
-
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis
-
Pizzini S, Bisognin A, Mandruzzato S et al. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics 2013; 14: 589.
-
(2013)
BMC Genomics
, vol.14
, pp. 589
-
-
Pizzini, S.1
Bisognin, A.2
Mandruzzato, S.3
-
9
-
-
84867740278
-
MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics
-
Xia H, Hui KM. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. Cancer Gene Ther 2012; 19: 723-30.
-
(2012)
Cancer Gene Ther
, vol.19
, pp. 723-730
-
-
Xia, H.1
Hui, K.M.2
-
10
-
-
84890708492
-
MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression
-
Frampton AE, Castellano L, Colombo T et al. MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression. Gastroenterology 2014; 146: 268-77e18.
-
(2014)
Gastroenterology
, vol.146
, pp. 268-77e18
-
-
Frampton, A.E.1
Castellano, L.2
Colombo, T.3
-
11
-
-
84885458012
-
MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster
-
Mohr AM, Bailey JM, Lewallen ME et al. MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster. PLoS One 2013; 8: e73306.
-
(2013)
PLoS One
, vol.8
, pp. e73306
-
-
Mohr, A.M.1
Bailey, J.M.2
Lewallen, M.E.3
-
12
-
-
84884967203
-
Micro RNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-beta actions
-
Ouyang H, Gore J, Deitz S et al. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-beta actions. Oncogene 2013; 33: 4664-74.
-
(2013)
Oncogene
, vol.33
, pp. 4664-4674
-
-
Ouyang, H.1
Gore, J.2
Deitz, S.3
-
13
-
-
34248200155
-
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma
-
Szafranska AE, Davison TS, John J et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007; 26: 4442-52.
-
(2007)
Oncogene
, vol.26
, pp. 4442-4452
-
-
Szafranska, A.E.1
Davison, T.S.2
John, J.3
-
14
-
-
84894415230
-
Hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration
-
Xu L, Li Q, Xu D et al. hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration. Int J Oncol 2014; 44: 459-66.
-
(2014)
Int J Oncol
, vol.44
, pp. 459-466
-
-
Xu, L.1
Li, Q.2
Xu, D.3
-
15
-
-
73449134501
-
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
-
Greither T, Grochola LF, Udelnow A et al. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 2010; 126: 73-80.
-
(2010)
Int J Cancer
, vol.126
, pp. 73-80
-
-
Greither, T.1
Grochola, L.F.2
Udelnow, A.3
-
16
-
-
84888352890
-
Targeting microRNAs in pancreatic cancer: Microplayers in the big game
-
Khan S, Ansarullah, Kumar D et al. Targeting microRNAs in pancreatic cancer: microplayers in the big game. Cancer Res 2013; 73: 6541-7.
-
(2013)
Cancer Res
, vol.73
, pp. 6541-6547
-
-
Khan, S.1
Ansarullah2
Kumar, D.3
-
17
-
-
34247862190
-
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
-
Bloomston M, Frankel WL, Petrocca F et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007; 297: 1901-8.
-
(2007)
JAMA
, vol.297
, pp. 1901-1908
-
-
Bloomston, M.1
Frankel, W.L.2
Petrocca, F.3
-
18
-
-
84884660965
-
Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: Meta-analysis, experimental validation and clinical significance
-
Ma MZ, Kong X, Weng MZ et al. Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance. J Exp Clin Cancer Res 2013; 32: 71.
-
(2013)
J Exp Clin Cancer Res
, vol.32
, pp. 71
-
-
Ma, M.Z.1
Kong, X.2
Weng, M.Z.3
-
19
-
-
84892689249
-
MicroRNA biomarkers in whole blood for detection of pancreatic cancer
-
Schultz NA, Dehlendorff C, Jensen BV et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA 2014; 311: 392-404.
-
(2014)
JAMA
, vol.311
, pp. 392-404
-
-
Schultz, N.A.1
Dehlendorff, C.2
Jensen, B.V.3
-
20
-
-
84884351594
-
Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9
-
Makawita S, Dimitromanolakis A, Soosaipillai A et al. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. BMC Cancer 2013; 13: 404.
-
(2013)
BMC Cancer
, vol.13
, pp. 404
-
-
Makawita, S.1
Dimitromanolakis, A.2
Soosaipillai, A.3
-
21
-
-
0021638331
-
Classification of pancreatitis
-
Sarner M, Cotton PB. Classification of pancreatitis. Gut 1984; 25: 756-9.
-
(1984)
Gut
, vol.25
, pp. 756-759
-
-
Sarner, M.1
Cotton, P.B.2
-
22
-
-
84877060316
-
Targeting miR-21 for the therapy of pancreatic cancer
-
Sicard F, Gayral M, Lulka H et al. Targeting miR-21 for the therapy of pancreatic cancer. Mol Ther 2013; 21: 986-94.
-
(2013)
Mol Ther
, vol.21
, pp. 986-994
-
-
Sicard, F.1
Gayral, M.2
Lulka, H.3
-
23
-
-
79953026892
-
MiR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor
-
Park JK, Henry JC, Jiang J et al. miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun 2011; 406: 518-23.
-
(2011)
Biochem Biophys Res Commun
, vol.406
, pp. 518-523
-
-
Park, J.K.1
Henry, J.C.2
Jiang, J.3
-
24
-
-
84892912591
-
Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-beta to promote proliferation
-
Gore AJ, Deitz SL, Palam LR et al. Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-beta to promote proliferation. J Clin Invest 2014; 124: 338-52.
-
(2014)
J Clin Invest
, vol.124
, pp. 338-352
-
-
Gore, A.J.1
Deitz, S.L.2
Palam, L.R.3
-
25
-
-
84855543629
-
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefi tinib resistance in lung cancers
-
Garofalo M, Romano G, Di Leva G et al. EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefi tinib resistance in lung cancers. Nat Med 2012; 18: 74-82.
-
(2012)
Nat Med
, vol.18
, pp. 74-82
-
-
Garofalo, M.1
Romano, G.2
Di Leva, G.3
-
26
-
-
80755163679
-
Signaling pathways in pancreatic cancer
-
Preis M, Korc M. Signaling pathways in pancreatic cancer. Crit Rev Eukaryot Gene Expr 2011; 21: 115-29.
-
(2011)
Crit Rev Eukaryot Gene Expr
, vol.21
, pp. 115-129
-
-
Preis, M.1
Korc, M.2
-
27
-
-
84861578195
-
Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer
-
Liu J, Gao J, Du Y et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer 2012; 131: 683-91.
-
(2012)
Int J Cancer
, vol.131
, pp. 683-691
-
-
Liu, J.1
Gao, J.2
Du, Y.3
-
28
-
-
84892583351
-
Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells
-
Takiuchi D, Eguchi H, Nagano H et al. Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells. Pancreatology 2013; 13: 517-23.
-
(2013)
Pancreatology
, vol.13
, pp. 517-523
-
-
Takiuchi, D.1
Eguchi, H.2
Nagano, H.3
-
29
-
-
80052445088
-
MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma
-
Preis M, Gardner TB, Gordon SR et al. MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma. Clin Cancer Res 2011; 17: 5812-21.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 5812-5821
-
-
Preis, M.1
Gardner, T.B.2
Gordon, S.R.3
-
30
-
-
54049115957
-
Analysis of microRNAs in pancreatic fi ne-needle aspirates can classify benign and malignant tissues
-
Szafranska AE, Doleshal M, Edmunds HS et al. Analysis of microRNAs in pancreatic fi ne-needle aspirates can classify benign and malignant tissues. Clin Chem 2008; 54: 1716-24.
-
(2008)
Clin Chem
, vol.54
, pp. 1716-1724
-
-
Szafranska, A.E.1
Doleshal, M.2
Edmunds, H.S.3
-
31
-
-
77951587943
-
MicroRNA expression profi ling to identify and validate reference genes for relative quantification in colorectal cancer
-
Chang KH, Mestdagh P, Vandesompele J et al. MicroRNA expression profi ling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 2010; 10: 173.
-
(2010)
BMC Cancer
, vol.10
, pp. 173
-
-
Chang, K.H.1
Mestdagh, P.2
Vandesompele, J.3
-
32
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method
-
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-8.
-
(2001)
Methods
, vol.25
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
33
-
-
84943987463
-
Multiple comparisons among means
-
Dunn OJ. Multiple comparisons among means. J Am Stat Assoc 1961; 56: 52-64.
-
(1961)
J Am Stat Assoc
, vol.56
, pp. 52-64
-
-
Dunn, O.J.1
-
35
-
-
79955921754
-
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
-
Conroy T, Desseigne F, Ychou M et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817-25.
-
(2011)
N Engl J Med
, vol.364
, pp. 1817-1825
-
-
Conroy, T.1
Desseigne, F.2
Ychou, M.3
-
36
-
-
84886741654
-
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
-
Von Hoff DD, Ervin T, Arena FP et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013; 369: 1691-703.
-
(2013)
N Engl J Med
, vol.369
, pp. 1691-1703
-
-
Von Hoff, D.D.1
Ervin, T.2
Arena, F.P.3
-
38
-
-
84865755577
-
MiRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts
-
Matthaei H, Wylie D, Lloyd MB et al. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res 2012; 18: 4713-24.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 4713-4724
-
-
Matthaei, H.1
Wylie, D.2
Lloyd, M.B.3
-
39
-
-
84863115480
-
MicroRNA alterations of pancreatic intraepithelial neoplasias
-
Yu J, Li A, Hong SM et al. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res 2012; 18: 981-92.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 981-992
-
-
Yu, J.1
Li, A.2
Hong, S.M.3
-
40
-
-
84864840525
-
Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue
-
Bauer AS, Keller A, Costello E et al. Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One 2012; 7: e34151.
-
(2012)
PLoS One
, vol.7
, pp. e34151
-
-
Bauer, A.S.1
Keller, A.2
Costello, E.3
-
41
-
-
84863229384
-
Serum microRNA expression profi le as a biomarker in the diagnosis and prognosis of pancreatic cancer
-
Liu R, Chen X, Du Y et al. Serum microRNA expression profi le as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 2012; 58: 610-8.
-
(2012)
Clin Chem
, vol.58
, pp. 610-618
-
-
Liu, R.1
Chen, X.2
Du, Y.3
-
42
-
-
70449700281
-
MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease
-
Wang J, Chen J, Chang P et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila) 2009; 2: 807-13.
-
(2009)
Cancer Prev Res (Phila)
, vol.2
, pp. 807-813
-
-
Wang, J.1
Chen, J.2
Chang, P.3
-
43
-
-
84892691965
-
Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer?
-
Buchsbaum DJ, Croce CM. Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer? JAMA 2014; 311: 363-5.
-
(2014)
JAMA
, vol.311
, pp. 363-365
-
-
Buchsbaum, D.J.1
Croce, C.M.2
-
44
-
-
33846595479
-
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
-
Locker GY, Hamilton S, Harris J et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006; 24: 5313-27.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5313-5327
-
-
Locker, G.Y.1
Hamilton, S.2
Harris, J.3
-
45
-
-
53349177819
-
Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases
-
Chen X, Ba Y, Ma L et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
-
(2008)
Cell Res
, vol.18
, pp. 997-1006
-
-
Chen, X.1
Ba, Y.2
Ma, L.3
-
46
-
-
43449102192
-
Detection of elevated levels of tumourassociated microRNAs in serum of patients with diff use large B-cell lymphoma
-
Lawrie CH, Gal S, Dunlop HM et al. Detection of elevated levels of tumourassociated microRNAs in serum of patients with diff use large B-cell lymphoma. Br J Haematol 2008; 141: 672-5.
-
(2008)
Br J Haematol
, vol.141
, pp. 672-675
-
-
Lawrie, C.H.1
Gal, S.2
Dunlop, H.M.3
-
47
-
-
80052032965
-
Biliary stricture and negative cytology: What next?
-
Cote GA, Sherman S. Biliary stricture and negative cytology: what next? Clin Gastroenterol Hepatol 2011; 9: 739-43.
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, pp. 739-743
-
-
Cote, G.A.1
Sherman, S.2
-
48
-
-
84891739183
-
A differential microRNA profi le distinguishes cholangiocarcinoma from pancreatic adenocarcinoma
-
Collins AL, Wojcik S, Liu J et al. A differential microRNA profi le distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. Ann Surg Oncol 2013; 21: 133-8.
-
(2013)
Ann Surg Oncol
, vol.21
, pp. 133-138
-
-
Collins, A.L.1
Wojcik, S.2
Liu, J.3
-
49
-
-
77955755505
-
Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered Micro-RNA expression in solid tumors
-
Sempere LF, Preis M, Yezefski T et al. Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered Micro-RNA expression in solid tumors. Clin Cancer Res 2010; 16: 4246-55.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 4246-4255
-
-
Sempere, L.F.1
Preis, M.2
Yezefski, T.3
-
50
-
-
84898761999
-
Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis
-
Nie S, Lo A, Wu J et al. Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. J Proteome Res 2014; 13: 1873-84.
-
(2014)
J Proteome Res
, vol.13
, pp. 1873-1884
-
-
Nie, S.1
Lo, A.2
Wu, J.3
-
51
-
-
84856695673
-
Circulating microRNAs: Novel biomarkers and extracellular communicators in cardiovascular disease?
-
Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 2012; 110: 483-95.
-
(2012)
Circ Res
, vol.110
, pp. 483-495
-
-
Creemers, E.E.1
Tijsen, A.J.2
Pinto, Y.M.3
|